Navigation Links
Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
Date:11/9/2009

d syncope were observed in clinical trials. Use INTUNIV with caution in treating patients who have experienced hypotension, bradycardia, heart block, or syncope, or who may have a condition that predisposes them to syncope; are treated concomitantly with antihypertensives or other drugs that can reduce blood pressure or heart rate or increase the risk of syncope. Heart rate and blood pressure should be measured prior to initiation of therapy, following dose increases, and periodically while on therapy. Patients should be advised to avoid becoming dehydrated or overheated.

Sedation and somnolence were commonly observed in clinical trials. The potential for additive sedative effects with CNS depressant drugs should be considered. Patients should be cautioned against operating heavy equipment or driving until they know how they respond to INTUNIV. Avoid use with alcohol.

Common adverse reactions in patients taking INTUNIV that may be dose related over the range of 1 to 4 mg/day include somnolence, sedation, abdominal pain, dizziness, hypotension/decreased blood pressure, dry mouth, and constipation.

About ADHD

ADHD is one of the most common psychiatric disorders in children and adolescents. Worldwide prevalence of ADHD is estimated at 5.3 percent (with large variability), according to a comprehensive systematic review of this topic published in 2007 in the American Journal of Psychiatry. In the United States, approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC).

ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. The specific etiolog
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
2. New Data Show Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using the Oppositional Subscale of the Conners ADHD Rating Scale
3. Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
4. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
5. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
6. Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
7. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
8. New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
9. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
10. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
11. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Yujiro S. Hata to its board of ... business and corporate development is a tremendous asset to ... and chief executive officer of Xencor. "Xencor faces a ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 ... it will release its second quarter 2015 financial results ... 2015.   In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
Breaking Medicine Technology:Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... Northern Ireland, Dec. 20, 2010 HeartSine Technologies ... the 14th annual Aisling Awards ceremony, November 25th, in ... who has made significant contributions to Belfast and surrounding ... the Belfast Media Group in 1997 to ...
... Calif., Dec. 20, 2010 Huntsman Gay Global Capital, ... the completion of a recapitalization of Sunquest Information Systems® ... recapitalization, led by Huntsman Gay, was done in partnership ... since 2007 and is retaining a significant stake in ...
Cached Medicine Technology:HeartSine Technologies Wins 2010 Aisling Award for Outstanding Achievement in Business 2Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems 2Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems 3
(Date:7/31/2015)... ... 31, 2015 , ... Indosoft, Inc., is pleased to announce a major update ... their flagship contact center ACD system for Asterisk-based call centers . The new ... script components to the agent only when wanted, and allows for validation of data ...
(Date:7/31/2015)... Minneapolis, Minn. (PRWEB) , ... July 31, 2015 ... ... software, is selected as a contributor for LeadingAge’s Center for Aging Services Technologies ... studies designed to help long-term and post-acute care providers understand the benefits of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Beaumont Hospital's Karmanos Center for Natural Birth . The Karmanos Center ... a safe natural childbirth experience. With nurses and caregivers that are trained in ...
(Date:7/31/2015)... ... 2015 , ... New Energy Works Timberframers invites the public to join their ... 2015 from 9am – 12pm. Timber frame raisings are special, celebrating both ... as the culmination of months of effort, planning, fundraising, and dreaming takes shape. ...
(Date:7/31/2015)... ... July 31, 2015 , ... An article entitled " Dentists ... a woman’s unfortunate experience having cosmetic skin procedures done by a family doctor ... blistering, swelling, bruising, and pain. This woman’s experience is only one in a ...
Breaking Medicine News(10 mins):Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3
... response has practical application, expert says , SUNDAY, Jan. 17 ... into why we miss things when they,re uncommon. , ... often don,t find it," said Jeremy Wolfe of Harvard Medical ... news release from Cell Press, which published a study on ...
... ... by advocating for physician patient relationships which ensure optimal patient care and well being, ... guidelines such as breast cancer screening that can negatively impact patients. , ... (PRWEB) January 17, 2010 -- ...
... The world-renowned wellness ... balm based on the timeless healing principles of ayurvedic medicine , ... Carlsbad, CA (PRWEB) January 17, 2010 -- Made ... this winter season. Adara Lip Balm heals dry, chapped lips with a signature blend of ...
... , - More relief goods, staff arrive, but challenges ... , - Agency reports "race against clock" to save lives ... , Jan. 16 World Vision relief ... a boost as relief goods began arriving in Haiti,s quake-ravaged capital city ...
... , ... Latin America , WASHINGTON , Jan. 16 ... Haiti relief efforts using a new Portuguese website called ... of American States announced. , AjudaPanamericana.org is the third language option ...
... , WASHINGTON , Jan. ... Development (USAID) Bureau for Global Health is sending additional specialists ... medical needs.  Reports indicate that thousands of individuals in makeshift ... Tuesday,s earthquake. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO ) , Global ...
Cached Medicine News:Health News:Southern Medical Association Takes Position on Breast Cancer Screening 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 3Health News:Southern Medical Association Takes Position on Breast Cancer Screening 4Health News:Pamper and Soothe Your Lips with the Chopra Center's New Adara Certified Organic Lip Balm 2Health News:HAITI QUAKE: World Vision Situation Update 2Health News:HAITI QUAKE: World Vision Situation Update 3Health News:HAITI QUAKE: World Vision Situation Update 4Health News:Haiti Relief Site Now in Portuguese 2Health News:Haiti Relief Site Now in Portuguese 3Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 3
... Further expanding the growing portfolio ... Pulse Oximeter is a compact, affordable ... advanced signal processing technology, it offers ... and is compatible with the complete ...
... of the revolutionary OxiMax® Pulse Oximetry ... combines Nellcor's best-in-class pulse oximetry with ... motion-tolerant OxiMax N-595 Pulse Oximeter is ... processing technology, which enables it to ...
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m...
The Model 340 is intended for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
Medicine Products: